Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
A novel CRISPR activation mouse enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
PubMed Full text in PMC Similar studies
The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma
PubMed Similar studies Analyze with GEO2R
Single-cell RNA sequencing of OCI-Ly18 tumors treated with CART19 plus vehicle (DMSO) or CART19 plus Venetoclax
Targeting mitochondrial structure sensitizes AML to Venetoclax
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Genetic determinants of venetoclax resistance
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Engineering ABT-737 Resistance in MYC-driven Lymphomas Identifies DHX9 as a Drug Response Modifier
PubMed Full text in PMC Similar studies Analyze with GEO2R
Prediction of Venetoclax Activity in Precursor B-ALL by Functional Assessment of Apoptosis Signaling
Defining TFAP4 transcriptional regulation in pre-leukemic Eμ-MYC pre-B lymphoma cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on